COMMUNIQUÉS West-GlobeNewswire

Iovance’s AMTAGVI™ (lifileucel) Receives U.S. FDA Accelerated Approval for Advanced Melanoma
16/02/2024
AMTAGVI is the first FDA-approved T cell therapy for a solid tumor cancer and first treatment option for advanced melanoma after anti-PD-1 and targeted therapy AMTAGVI deploys patient-specific immune cells that [...]
Sharps Technology Planning To Collaborate With Roncadelle To Support Global Distribution And Sales Of High Quality, Innovative, Safer Drug Delivery Systems
16/02/2024
Sharps and Roncadelle are Joining Forces to Supply Drug Delivery Systems to the International HealthCare Market Through an Expanded Network of North American 3PL Distribution Partnerships NEW YORK, Feb. 16, 2024 (GLOBE [...]
Astiva Health, Inc. Celebrates Grand Opening of New Activity Center in Los Angeles-Koreatown with Support from Rep. Michelle Steel
16/02/2024
ORANGE, Calif. , Feb. 16, 2024 (GLOBE NEWSWIRE) -- via IBN -- Astiva Health Inc. , a fast-growing Medicare Advantage Prescription Drug (MAPD) health plan dedicated to reshaping personalized and comprehensive healthcare [...]
FDA approves Xolair as first and only medicine for children and adults with one or more food allergies
16/02/2024
Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate small amounts of [...]
Healthcare Integrated Technologies, Inc. Signs Letter of Intent to Acquire Glass 8 Holdings, LLC in its Initial Move Toward Becoming a More Diversified Holding Company
16/02/2024
Knoxville, Tennessee, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies, Inc. (“HiTC”), a leading innovator of healthcare technology solutions, has announced today the signing of a non-binding letter [...]
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
16/02/2024
Conference Call Scheduled for Wednesday, February 28, 2024 at 9:00 AM ET PORTLAND, Maine, Feb. 16, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health [...]
CLEARDAY LIVING IMPLEMENTS SMART TOILET INNOVATION DESIGNED TO IMPROVE RESIDENT HEALTH
16/02/2024
Toi Labs’ TrueLoo ® Provides Real-Time Precision Data Collection and Analysis Naples, FL, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Clearday Living , a business unit of Clearday (OTCQX CLRD) a long-term care provider and leader [...]
Mdxhealth Announces Resignation of Board Member
16/02/2024
Mdxhealth Announces Resignation of Board Member IRVINE, CA, and HERSTAL, BELGIUM – February 16, 2024 ( GlobeNewswire ) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a commercial-stage precision [...]
Intelligent Bio Solutions Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement and Confirms Compliance with Minimum Stockholders’ Equity Requirement
16/02/2024
NEW YORK, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("INBS" or the "Company") (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today [...]
PetMeds® to Give Away Free Pet Food for a Year to Three Lucky Pet Owners and $1,000 in PetMeds® Credits to Three Local Animal Shelters
16/02/2024
The giveaway comes as PetMeds® partners with Hill’s Pet Nutrition to make Science Diet available through petmeds.com, starting March 1 DELRAY BEACH, Fla., Feb. 16, 2024 (GLOBE NEWSWIRE) -- PetMed Express , Inc. (NASDAQ [...]
Allogene Therapeutics to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments Related to the December 2020 Formation of the Allogene Overland Biopharm Joint Venture in Asia
16/02/2024
No Impact on Cash, Cash Equivalents and Marketable Investments, Cash Runway or Business Operations Company Targeting On or Before March 14, 2024 to File Amended Financial Statements and Report Fourth Quarter and Full [...]
Autonomix Begins Human POC Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market
16/02/2024
Site initiation completed for first study ever to evaluate radiofrequency (RF) ablation in a transvascular approach to reduce the pain associated with pancreatic cancer THE WOODLANDS, TX, Feb. 16, 2024 (GLOBE NEWSWIRE [...]
Arcutis to Report Fourth Quarter and Full Year 2023 Financial Results
16/02/2024
Quarterly investor conference call and webcast scheduled for Tuesday, February 27 at 8:30 a.m. ET WESTLAKE VILLAGE, Calif., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial- [...]
Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering
16/02/2024
FREEHOLD, N.J., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (NYSE American: CHRO) (“Chromocell” or the “Company”), a clinical-stage biotech company focused on developing and commercializing new [...]
Kinnate Biopharma Inc. Enters into Agreement to be Acquired by XOMA Corporation for Between $2.3352 and $2.5879 Per Share in Cash, Plus One Contingent Value Right per Share
16/02/2024
SAN FRANCISCO and SAN DIEGO, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc . (Nasdaq: KNTE) (“Kinnate” or the “Company”), a clinical-stage precision oncology company, today announced it has entered into a [...]
Hepion Pharmaceuticals Announces Exercise of Warrants for Approximately $2.0 Million Aggregate Gross Proceeds
16/02/2024
EDISON, N.J., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on artificial intelligence assisted therapeutic drug development for the [...]
XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right
16/02/2024
Upon closing, XOMA anticipates adding approximately $9.5 million in cash to its balance sheet and several early-stage programs to potentially add to its royalty portfolio EMERYVILLE, Calif., Feb. 16, 2024 (GLOBE [...]
Annual General Meeting in ALK-Abelló A/S on 14 March 2024
16/02/2024
ALK ( ALKB:DC / OMX: ALK B / AKBLF ): The Annual General Meeting of ALK-Abelló A/S will take place on Thursday, 14 March 2024 at 4:00 PM (CET) at ALK-Abelló A/S, 1 Bøge Allé, 2970 Hørsholm, Denmark. The agenda of the [...]
Y-mAbs to Announce Fourth Quarter and Full Year 2023 Financial and Operating Results on February 29, 2024
16/02/2024
NEW YORK, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) today announced that it will report its financial results for the quarter and full year ended December 31 [...]

Pages